Claims for Patent: 7,732,137

Summary for Patent: 7,732,137

Title:	Selecting animals for desired genotypic or potential phenotypic properties
Abstract:	The invention relates to methods to select animals, such as mammals, particularly domestic animals, such as breeding animals or animals destined for slaughter, for having desired genotypic or potential phenotypic properties, in particular, related to muscle mass and/or fat deposition lean meat, lean back fat, sow prolificacy and/or sow longevity. Provided is a method for selecting an animal for having desired genotypic or potential phenotypic properties comprising testing the animal, a parent of the animal or its progeny for the presence of a nucleic acid modification affecting the activity of an evolutionary conserved CpG island, located in intron 3 of an IGF2 gene and/or for the presence of a nucleic acid modification affecting binding of a nuclear factor to an IGF2 gene.
Inventor(s):	Andersson; Leif (Uppsala, SE), Andersson; Goran (Uppsala, SE), Georges; Michel (Villers-aux-Tours, BE), Buys; Nadine (Leuven, BE)
Assignee:	University of Liege (Liege, BE) Melica HB (Uppsala, SE) Gentec N.V. (Lokeren, BE)
Application Number:	11/357,718
Patent Claims:	1. A method for selecting a pig having a desired genotypic property, said method comprising: testing a population of pigs for the presence of a nucleic acid sequence; wherein said nucleic acid sequence comprises a nucleotide substitution in 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO: 1) wherein said nucleic acid sequence has increased mobility relative to 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO:1) during gel electrophoresis after exposure of said nucleic acid sequence and 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO:1) to extracts from C2C12 myoblast cells; and selecting, from the population of pigs tested, a pig comprising said nucleic acid sequence, a parent of said pig, or a progeny of said pig. 2. The method according to claim 1, wherein said nucleotide substitution comprises a substitution of A for G at position 19 of 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO:1). 3. A method for selecting a pig having desired genotypic or potential phenotypic properties, the method comprising: testing said pig, a parent of said pig or its progeny, for the presence of a nucleic acid modification located in intron 3 of an IGF2 gene, wherein the nucleic acid modification comprises a nucleotide substitution comprising a G to A transition at IGF2-intron3-nt3072, and selecting, from a population of pigs tested, a pig comprising said nucleic acid sequence, a parent of said pig, or a progeny of said pig; wherein said desired genotypic or potential phenotypic properties comprise muscle mass, teat number, fat deposition, lean meat, lean back fat, sow prolificacy and/or sow longevity. 4. The method according to claim 3, wherein said sow prolificacy includes such phenotypic expressions as teat number, number of piglets born alive, litter size, number of total born and/or number of weaned piglets. 5. The method according to claim 3, wherein said sow longevity includes such phenotypic expressions as parity and/or average number of cycles per sow. 6. A method of enhancing a breeding program, the method comprising: selecting a pig according to the method of claim 5; and incorporating the selected pig in a pig breeding program so as to enhance performance of breeding pigs or pigs destined for slaughter and to facilitate introgression of the nucleic acid modification to additional breeds. 7. A method for selecting a pig having a desired genotypic property, said method comprising: testing a population of pigs for the presence of a nucleic acid sequence; wherein said nucleic acid sequence is located in a CpG island within intron 3 of an IGF2 gene and has at least 50% homology with the sequence 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO: 1); wherein said nucleic acid sequence has increased mobility relative to 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO:1) during gel electrophoresis after exposure of said nucleic acid sequence and 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO:1) to extracts from C2C12 myoblast cells; and selecting, from the population of pigs tested, a pig comprising said nucleic acid sequence, a parent of said pig, or a progeny of said pig. 8. The method according to claim 7, wherein said nucleic acid sequence comprises a substitution of A for G at position 19 of 5'-GATCCTTCGCCTAGGCTCNCAGCGCGGGAGCGA-3' (SEQ ID NO: 1).

Details for Patent 7,732,137

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2023-01-10
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2023-01-10
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2023-01-10